190 related articles for article (PubMed ID: 36563680)
1. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.
Teng H; Wang Y; Sui X; Fan J; Li S; Lei X; Shi C; Sun W; Song M; Wang H; Dong D; Geng J; Zhang Y; Zhu X; Cai Y; Li Y; Li B; Min Q; Wang W; Zhan Q
Cancer Cell; 2023 Jan; 41(1):124-138.e6. PubMed ID: 36563680
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.
Yi Y; Shen L; Shi W; Xia F; Zhang H; Wang Y; Zhang J; Wang Y; Sun X; Zhang Z; Zou W; Yang W; Zhang L; Zhu J; Goel A; Ma Y; Zhang Z
Clin Cancer Res; 2021 Mar; 27(5):1329-1340. PubMed ID: 33298472
[TBL] [Abstract][Full Text] [Related]
3. Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy.
Sun Y; Zhang X; Jin C; Yue K; Sheng D; Zhang T; Dou X; Liu J; Jing H; Zhang L; Yue J
J Transl Med; 2023 Mar; 21(1):221. PubMed ID: 36967379
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
5. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study.
Shi W; Shen L; Zou W; Wang J; Yang J; Wang Y; Liu B; Xie L; Zhu J; Zhang Z
Front Cell Infect Microbiol; 2020; 10():562463. PubMed ID: 33363048
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
Serna G; Ruiz-Pace F; Hernando J; Alonso L; Fasani R; Landolfi S; Comas R; Jimenez J; Elez E; Bullman S; Tabernero J; Capdevila J; Dienstmann R; Nuciforo P
Ann Oncol; 2020 Oct; 31(10):1366-1375. PubMed ID: 32569727
[TBL] [Abstract][Full Text] [Related]
7. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
He L; Chang H; Qi Y; Zhang B; Shao Q
Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.
Kim HJ; Bae SB; Jeong D; Kim ES; Kim CN; Park DG; Ahn TS; Cho SW; Shin EJ; Lee MS; Baek MJ
Oncol Rep; 2014 Dec; 32(6):2493-500. PubMed ID: 25241658
[TBL] [Abstract][Full Text] [Related]
9. RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9-caspase-3-dependent apoptotic pathway.
Yan X; Chen J; Meng Y; He C; Zou S; Li P; Chen M; Wu J; Ding WQ; Zhou J
Cancer Med; 2019 Jun; 8(6):3094-3104. PubMed ID: 31033216
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Zhang S; Li N; Wang F; Liu H; Zhang Y; Xiao J; Qiu W; Zhang C; Fan X; Qiu M; Li M; Tang H; Fan S; Wang J; Luo H; Li X; Lin J; Huang Y; Liang L
Pharmacol Res; 2023 Nov; 197():106974. PubMed ID: 37898442
[TBL] [Abstract][Full Text] [Related]
11. Gut microbes promote chemoradiotherapy resistance via metabolic cross-feeding.
Wong CC; Fong W; Yu J
Cancer Cell; 2023 Jan; 41(1):12-14. PubMed ID: 36563683
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
[TBL] [Abstract][Full Text] [Related]
13. Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
Ji D; Yi H; Zhang D; Zhan T; Li Z; Li M; Jia J; Qiao M; Xia J; Zhai Z; Song C; Gu J
Cancer Immunol Res; 2018 Nov; 6(11):1401-1416. PubMed ID: 30282671
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Huang MY; Huang CW; Wang JY
Kaohsiung J Med Sci; 2020 Mar; 36(3):152-159. PubMed ID: 31814296
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
16. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
[No Abstract] [Full Text] [Related]
17. An integrated multiomics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-fluorouracil.
D'Angelo E; Pastrello C; Biccari A; Marangio A; Sensi F; Crotti S; Fassan M; Jurisica I; Pucciarelli S; Agostini M
Int J Cancer; 2023 Jul; 153(2):437-449. PubMed ID: 36815540
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
20. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]